In a groundbreaking development, scientists from Amsterdam University Medical Center (UMC) and Radboud UMC have introduced an artificial intelligence (AI) model that has the potential to drastically reduce the time and complexity involved in finding the right antidepressant for patients with major depressive disorder. This novel AI approach can predict the effectiveness of a specific
